| Value | ₹150.0 Cr |
|---|
BSE filing, NSE: JLHL. Summary written from the filing by ALFA Finder's alert engine.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹256.75
- Market cap
- ₹8,417 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 45.1×Sector 52.0×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY
Jupiter Life Line Hospitals Debt & Borrowing: ₹500 Cr
Jupiter Life Line Hospitals secured a Rs. 500 Crore term loan from HDFC Bank for capital expenditure, including a Rs. 300 Crore LC sublimit.
- Value
- ₹500.0 Cr
Other acquisition announcements
All →MosChip Technologies Acquisition Worth ₹266.7 Cr
MosChip will acquire Vayavya Labs for Rs.266.71 Crore in cash and shares. Completion awaits RBI and exchange approvals and shareholder approval of a preferential issue.
- Value
- ₹266.7 Cr
- Execution
- Within 15 days of the later of receipt of all requisite approvals or shareholder approval of the preferential issue to VLPL sellers
Hexaware Technologies Acquisition
Hexaware Technologies announced amalgamation of two wholly owned step-down subsidiaries into its Canadian subsidiary. No cash consideration is involved, and the merger is internal group restructuring.
Zensar Technologies Acquisition
Zensar's board approved merging its wholly owned subsidiary M3bi India into the parent. No consideration or share issuance is involved, and NCLT sanction is pending.
ICICI Lombard General Insurance Company Acquisition Worth ₹172 Cr
ICICI Lombard disclosed that it acquired Rs.172 Crore of State Bank of India shares on October 28, 2026, in its ordinary-course investment function. Its cumulative holding in SBI is now 0.02%.
- Value
- ₹172.0 Cr
- Execution
- Investment made in multiple tranches over a period of time
Emkay Global Financial Services Acquisition Worth ₹30 Cr
Emkay Global will buy Emkay Capital Private Limited for Rs 30 Crore in cash. The related-party deal is expected to complete within 90 days.
- Value
- ₹30.00 Cr
Jindal Stainless Acquisition Worth ₹5.08 Cr
Jindal Stainless acquired an additional ~7% stake in Ampin C&I Three, taking its holding to 24.21%. The cash cost is ~₹5.08 crore for a 40 MW captive solar project.
- Value
- ₹5.08 Cr
- solar captive capacity
- 40.0 MW